{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:26:05Z","timestamp":1794097565194,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004530","name":"Universiti Putra Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116675","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T02:10:00Z","timestamp":1720923000000},"page":"116675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Exploring quinoxaline derivatives: An overview of a new approach to combat antimicrobial resistance"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-625X","authenticated-orcid":false,"given":"Hena","family":"Khatoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Munirah","family":"Mohd Faudzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116675_bib2","unstructured":"Antimicrobial resistant bacteria, Better Health Channel (n.d.). https:\/\/www.betterhealth.vic.gov.au\/site-5\/health\/conditionsandtreatments\/antibiotic-resistant-bacteria."},{"key":"10.1016\/j.ejmech.2024.116675_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.37201\/req\/022.2022","article-title":"Impact of Staphylococcus aureus bacteremia in COVID-19 patients","volume":"35","author":"Perez","year":"2022","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"10.1016\/j.ejmech.2024.116675_bib5","first-page":"1","article-title":"Future pandemics might be caused by bacteria and not viruses: recent advances in medical preventive practice","volume":"16","author":"Salazar","year":"2022","journal-title":"PubMed"},{"key":"10.1016\/j.ejmech.2024.116675_bib6","first-page":"688","article-title":"A global pandemic treaty must address antimicrobial resistance, the journal of law, medicine & ethics\/the journal of law","volume":"49","author":"Wilson","year":"2021","journal-title":"Med. Ethics"},{"key":"10.1016\/j.ejmech.2024.116675_bib7","author":"Programme","year":"2023","journal-title":"Global Tuberculosis Rep."},{"key":"10.1016\/j.ejmech.2024.116675_bib8","series-title":"Cancer","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116675_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/bjbs.2023.11387","article-title":"Antimicrobial resistance (AMR)","volume":"80","author":"Tang","year":"2023","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.ejmech.2024.116675_bib10","author":"Mamedov"},{"key":"10.1016\/j.ejmech.2024.116675_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2006.07.006","article-title":"Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines","volume":"42","author":"Khan","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib12","first-page":"386","article-title":"Exploring potential of quinoxaline moiety","volume":"3","author":"Patidar","year":"2011","journal-title":"Int. J. Pharmtech Res."},{"key":"10.1016\/j.ejmech.2024.116675_bib13","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/j.jscs.2012.12.011","article-title":"Heterocyclic systems containing bridgehead nitrogen atom: synthesis and antimicrobial activity of thiadiazolo[2\u2032,3\u2032:2,3]imidazo[4,5-B]quinoxaline","volume":"20","author":"Teja","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116675_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.11.064","article-title":"Quinoxaline: an insight into the recent pharmacological advances","volume":"143","author":"Tariq","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib15","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.bmcl.2017.02.049","article-title":"New hydrazine and hydrazide quinoxaline 1,4-di- N -oxide derivatives: in silico ADMET, antiplasmodial and antileishmanial activity","volume":"27","author":"Quiliano","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116675_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134443","article-title":"A novel of quinoxaline derivatives tagged with pyrrolidinyl scaffold as a new class of antimicrobial agents: design, synthesis, antimicrobial activity, and molecular docking simulation","volume":"1274","author":"Abdelgalil","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116675_bib17","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2174\/1389203724666230227115305","article-title":"Caspase-3 activators as anticancer agents","volume":"24","author":"Srivastava","year":"2023","journal-title":"Current Protein Peptide Sci. Current Protein Peptide Sci."},{"key":"10.1016\/j.ejmech.2024.116675_bib18","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijerph110303233","article-title":"Effect of ampicillin, streptomycin, penicillin and tetracycline on metal resistant and non-resistant Staphylococcus aureus","volume":"11","author":"Chudobova","year":"2014","journal-title":"Int. J. Environ. Res. Public Health\/Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ejmech.2024.116675_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jegh.2015.04.002","article-title":"First and second line drug resistance among treatment na\u00efve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi","volume":"5","author":"Myneedu","year":"2015","journal-title":"J. Epidemiol. Global Health"},{"key":"10.1016\/j.ejmech.2024.116675_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215666","article-title":"Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: a cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam","volume":"14","author":"Peters","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116675_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","article-title":"Metallo\u2010\u03b2\u2010lactamase structure and function","volume":"1277","author":"Palzkill","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2024.116675_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Van Duin","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.ejmech.2024.116675_bib23","first-page":"S28","article-title":"The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infectious Diseases (Online. Uni. Chicago Press)\/ J. Infectious Dis."},{"key":"10.1016\/j.ejmech.2024.116675_bib24","series-title":"Enterobacter Infections and Antimicrobial Drug Resistance","first-page":"175","author":"Anju","year":"2020"},{"key":"10.1016\/j.ejmech.2024.116675_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2024.116675_bib26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/microorganisms10122316","article-title":"An overview of macrolide resistance in streptococci: prevalence, mobile elements and dynamics","volume":"10","author":"Berbel","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2024.116675_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1568026033452537","article-title":"Fluoroquinolones: action and resistance","volume":"3","author":"Drlica","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib28","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/1462-2920.15760","article-title":"Directed evolution predicts cytochrome b G37V target site modification as probable adaptive mechanism towards the QiI fungicide fenpicoxamid in Zymoseptoria tritici","volume":"24","author":"Fouch\u00e9","year":"2021","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ibmb.2017.06.013","article-title":"Investigation of the contribution of RyR target-site mutations in diamide resistance by CRISPR\/Cas9 genome modification in Drosophila","volume":"87","author":"Douris","year":"2017","journal-title":"Insect Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.116675_bib30","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1021\/ja5030657","article-title":"Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics","volume":"136","author":"Fishovitz","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116675_bib31","first-page":"1","article-title":"Antimicrobial resistance mechanisms amongCampylobacter","author":"Wieczorek","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2024.116675_bib32","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.77.7.3974","article-title":"Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli","volume":"77","author":"McMurry","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116675_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415779","article-title":"Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa","volume":"23","author":"Lorusso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116675_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01031-21","article-title":"Cryo-EM determination of eravacycline-bound structures of the ribosome and the multidrug efflux pump AdeJ of acinetobacter baumannii","volume":"12","author":"Zhang","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2024.116675_bib35","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/biology11091328","article-title":"Drug efflux pump inhibitors: a promising approach to counter multidrug resistance in gram-negative pathogens by targeting AcrB protein from AcrAB-TolC multidrug efflux pump from Escherichia coli","volume":"11","author":"Alenazy","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ejmech.2024.116675_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00408","article-title":"MexXY multidrug efflux system of Pseudomonas aeruginosa","volume":"3","author":"Morita","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/antibiotics12010180","article-title":"Update on the discovery of efflux pump inhibitors against critical priority gram-negative bacteria","volume":"12","author":"Compagne","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2024.116675_bib38","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3390\/microorganisms11071690","article-title":"Outer membrane porins contribute to antimicrobial resistance in gram-negative bacteria","volume":"11","author":"Zhou","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2024.116675_bib39","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/AAC.49.4.1432-1440.2005","article-title":"Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of acinetobacter baumannii : natural insertional inactivation of a gene encoding a member of a novel family of \u03b2-barrel outer membrane proteins","volume":"49","author":"Mussi","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116675_bib40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","article-title":"The biofilm life cycle: expanding the conceptual model of biofilm formation","volume":"20","author":"Sauer","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant infections: adhesion, biofilm formation and immune evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00253-020-10349-w","article-title":"Prevention of biofilm formation by quorum quenching","volume":"104","author":"Paluch","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116675_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116675_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/antibiotics12020328","article-title":"Horizontal gene transfer of antibiotic resistance genes in biofilms","volume":"12","author":"Michaelis","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2024.116675_bib45","article-title":"Biofilms: hot spots of horizontal gene transfer (HGT) in aquatic environments, with a focus on a new HGT mechanism, FEMS Microbiology Ecology\/FEMS Microbiology","volume":"96","author":"Abe","year":"2020","journal-title":"Ecology"},{"key":"10.1016\/j.ejmech.2024.116675_bib46","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"PubMed"},{"key":"10.1016\/j.ejmech.2024.116675_bib47","series-title":"ANTIMICROBIAL RESISTANCE (AMR) \u2013 Dr Rajiv Desai","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116675_bib48","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00248-017-0985-z","article-title":"The threat of antimicrobial resistance on the human microbiome","volume":"74","author":"Brinkac","year":"2017","journal-title":"Microb. Ecol."},{"key":"10.1016\/j.ejmech.2024.116675_bib49","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1172\/JCI72333","article-title":"Antibiotics and the gut microbiota","volume":"124","author":"Modi","year":"2014","journal-title":"J. Clin. Invest.\/J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116675_bib50","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S1473-3099(20)30003-7","article-title":"The lancet infectious diseases commission on antimicrobial resistance: 6 years later, lancet","volume":"20","author":"Laxminarayan","year":"2020","journal-title":"Infect. Dis. Lancet. Infectious Dis."},{"key":"10.1016\/j.ejmech.2024.116675_bib51","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1021\/es405348h","article-title":"Increased waterborne blaNDM-1 resistance gene abundances associated with seasonal human pilgrimages to the upper Ganges River","volume":"48","author":"Ahammad","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejmech.2024.116675_bib52","article-title":"Potential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low-, middle- and high-income countries","volume":"369","author":"Kookana","year":"2014","journal-title":"Philosoph. Transact. Royal Soc. Biol. Sci."},{"key":"10.1016\/j.ejmech.2024.116675_bib53","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(18)30072-0","article-title":"A colistin crisis in India","volume":"18","author":"Davies","year":"2018","journal-title":"Lancet. Infect. Dis. Lancet. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116675_bib54","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.envint.2017.11.003","article-title":"Exposure to and colonisation by antibiotic-resistant E. coli in UK coastal water users: environmental surveillance, exposure assessment, and epidemiological study (Beach Bum Survey)","volume":"114","author":"Leonard","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.ejmech.2024.116675_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae \u2013A case\u2013control study in a low prevalence country","volume":"8","author":"S\u00f8raas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116675_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","article-title":"Antibiotic resistance in the environment","volume":"20","author":"Larsson","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105059","article-title":"Soil biota, antimicrobial resistance and planetary health","volume":"131","author":"Zhu","year":"2019","journal-title":"Environ. Int."},{"key":"10.1016\/j.ejmech.2024.116675_bib58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ejmech.2024.116675_bib59","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"<p>Antimicrobial resistance: implications and costs<\/p>","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116675_bib60","doi-asserted-by":"crossref","first-page":"s27","DOI":"10.1017\/ash.2023.80","article-title":"SG-APSIC1081: healthcare cost of antibiotic resistant infections: a hospital-based study in Vietnam","volume":"3","author":"LanPham","year":"2023","journal-title":"Antimicrobial Stewardship & Healthcare Epidemiol."},{"key":"10.1016\/j.ejmech.2024.116675_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/tropicalmed4010054","article-title":"Antimicrobial resistance (AMR) in the food chain: trade, one health and codex","volume":"4","author":"George","year":"2019","journal-title":"Tropical Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116675_bib62","unstructured":"Coronavirus Disease 2019, Centers for Disease Control and Prevention (n.d.). https:\/\/www.cdc.gov\/media\/releases\/2022\/s0712-Antimicrobial-Resistance.html."},{"key":"10.1016\/j.ejmech.2024.116675_bib63","series-title":"New Report Calls for Urgent Action to Avert Antimicrobial Resistance Crisis","year":"2019"},{"key":"10.1016\/j.ejmech.2024.116675_bib64","unstructured":"2020 Report | Antibiotic Use | CDC. (n.d.). https:\/\/www.cdc.gov\/antibiotic-use\/stewardship-report\/2020.html."},{"key":"10.1016\/j.ejmech.2024.116675_bib65","unstructured":"Antibiotic Use in the United States, 2018 Update: Progress and Opportunities | Antibiotic Use | CDC. (n.d.). https:\/\/www.cdc.gov\/antibiotic-use\/stewardship-report\/2018.html."},{"key":"10.1016\/j.ejmech.2024.116675_bib66","unstructured":"National Infection Prevention and Control Manual: Home. (n.d.). https:\/\/www.nipcm.hps.scot.nhs.uk\/."},{"key":"10.1016\/j.ejmech.2024.116675_bib67","unstructured":"Guidelines Library | Infection Control | CDC. (n.d.). https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/index.html."},{"key":"10.1016\/j.ejmech.2024.116675_bib68","unstructured":"National Infection Prevention and Control Manual | National Services Scotland. (n.d.). National Services Scotland. https:\/\/www.nss.nhs.scot\/antimicrobial-resistance-and-healthcare-associated-infection\/national-policies-guidance-and-evidence\/national-infection-prevention-and-control-manual\/."},{"key":"10.1016\/j.ejmech.2024.116675_bib69","series-title":"Regulation Bans Antibiotics as Growth Promoters in Animal Feed","author":"Cordis","year":"2003"},{"key":"10.1016\/j.ejmech.2024.116675_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227973","article-title":"Surveys of knowledge and awareness of antibiotic use and antimicrobial resistance in general population: a systematic review","volume":"15","author":"Kosiyaporn","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116675_bib71","series-title":"Financial Report 2020 | GARDP, GARDP","year":"2022"},{"key":"10.1016\/j.ejmech.2024.116675_bib72","author":"Division"},{"key":"10.1016\/j.ejmech.2024.116675_bib73","unstructured":"Why One Health? - One Health Commission, (n.d.). https:\/\/www.onehealthcommission.org\/en\/why_one_health\/."},{"key":"10.1016\/j.ejmech.2024.116675_bib74","article-title":"Quinoxaline: a comprehension of current pharmacological advancement in medicinal chemistry","volume":"5","author":"Suthar","year":"2022","journal-title":"European J. Med. Chem. Rep."},{"key":"10.1016\/j.ejmech.2024.116675_bib75","doi-asserted-by":"crossref","DOI":"10.2174\/0113852728295463240216074814","article-title":"A focussed analysis of \u0392-cyclodextrins for quinoxaline derivatives synthesis","volume":"28","author":"Khatoon","year":"2024","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101438","article-title":"Optimizing reaction efficiency: microwave-supported synthesis of quinoxaline-based compounds","author":"Khatoon","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib77","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1039\/D1RA07559D","article-title":"Synthesis of novel antibacterial and antifungal quinoxaline derivatives","volume":"12","author":"Tang","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116675_bib78","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molstruc.2019.02.074","article-title":"Quinoxaline-PABA bipartite hybrid derivatization approach: design and search for antimicrobial agents","volume":"1184","author":"Patel","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116675_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103841","article-title":"Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies","volume":"99","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib80","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1002\/jhet.3716","article-title":"Exploration of quinoxaline derivatives as antimicrobial and anticancer agents","volume":"56","author":"Bayoumi","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib81","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1080\/10406638.2020.1833052","article-title":"Synthesis, antibacterial activity and molecular docking study of a series of 1,3-oxazole-quinoxaline amine hybrids","volume":"42","author":"Keivanloo","year":"2020","journal-title":"Polycycl. Aromat. Comp."},{"key":"10.1016\/j.ejmech.2024.116675_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130273","article-title":"Host-quest inclusion complex of quinoxaline-1,4-dioxide derivative with 2-hydroxypropyl-\u03b2-cyclodextrin: preparation, characterization, and antibacterial activity","volume":"1235","author":"Chouker","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116675_bib83","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00706-019-02449-9","article-title":"Antimicrobial evaluation and action mechanism of chalcone derivatives containing quinoxaline moiety","volume":"150","author":"Xia","year":"2019","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib84","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1002\/slct.201903361","article-title":"Rhodanine\u2010furan bis\u2010heterocyclic frameworks synthesis via green one\u2010pot sequential six\u2010component reactions: a synthetic and computational study","volume":"4","author":"Hooshmand","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.116675_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133970","article-title":"Comprehensive review on the Bis\u2013heterocyclic compounds and their anticancer efficacy","volume":"1271","author":"Al-Jumaili","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2024.116675_bib86","doi-asserted-by":"crossref","first-page":"44312","DOI":"10.1021\/acsomega.3c07125","article-title":"Novel scaffolds based on bis-thiazole connected to quinoxaline or thienothiophene through 2-phenoxy-N-arylacetamide groups as new hybrid molecules: synthesis, antibacterial activity, and molecular docking investigations","volume":"8","author":"Salem","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116675_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202305073","article-title":"Synthesis of a series of quinoxaline derivatives and their antibacterial effectiveness against pathogenic bacteria","volume":"9","author":"Khatoon","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2024.116675_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101389","article-title":"Synthesis of quinoxaline derivatives using different solvent systems, their potent antibacterial activities and molecular docking","author":"Khatoon","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib89","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s13738-020-02119-2","article-title":"Green routes for the synthesis of new pyrazole bearing biologically active imidiazolyl, pyridine and quinoxaline derivatives as promising antimicrobial and antioxidant agents","volume":"18","author":"Ibrahim","year":"2021","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116675_bib90","doi-asserted-by":"crossref","first-page":"24573","DOI":"10.1021\/acsomega.3c02797","article-title":"Synthesis, antifungal activities, molecular docking and molecular dynamic studies of novel quinoxaline-triazole compounds","volume":"8","author":"Osmaniye","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116675_bib91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.archoralbio.2016.10.013","article-title":"Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp","volume":"73","author":"Peixoto","year":"2017","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejmech.2024.116675_bib92","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jhet.3431","article-title":"Design, synthesis, and characterization of quinoxaline derivatives as a potent antimicrobial agent","volume":"56","author":"Dewangan","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24030-x","article-title":"One pot synthesis of two potent Ag(I) complexes with quinoxaline ligand, X-ray structure, Hirshfeld analysis, antimicrobial, and antitumor investigations","volume":"12","author":"El-Naggar","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116675_bib94","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1080\/07391102.2022.2086176","article-title":"Synthetic approach toward spiro quinoxaline-\u03b2-lactam based heterocyclic compounds: spectral characterization, SAR, pharmacokinetic and biomolecular interaction studies","volume":"41","author":"Dabhi","year":"2022","journal-title":"J. Biomol. Struct. Dynamics\/J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.ejmech.2024.116675_bib95","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2147\/IDR.S401371","article-title":"Evaluation of the antibacterial activity of quinoxaline derivative compound against methicillin-resistant Staphylococcus aureus","volume":"16","author":"Elfadil","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2024.116675_bib96","author":"Programme","year":"2015","journal-title":"Global Tuberculosis Rep."},{"key":"10.1016\/j.ejmech.2024.116675_bib97","first-page":"1","article-title":"New conjugates of quinoxaline as potent antitubercular and antibacterial agents","author":"Peraman","year":"2016","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116675_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127784","article-title":"Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity","volume":"35","author":"Raphoko","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.116675_bib99","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/ph16111565","article-title":"Novel derivatives of quinoxaline-2-carboxylic acid 1,4-dioxides as antimycobacterial agents: mechanistic studies and therapeutic potential","volume":"16","author":"Frolova","year":"2023","journal-title":"Pharmaceuticals"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:48:58Z","timestamp":1730720938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424005555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":98,"alternative-id":["S0223523424005555"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116675","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring quinoxaline derivatives: An overview of a new approach to combat antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116675"}}